Health
BioNTech/Pfizer Vaccination Analysis Confirms High Overall Efficacy – Clinical OMICs News
Results from an analysis of COVID-19 vaccination data from Israel show over 90% protection from SARS-CoV-2 infection with the BioNTech/Pfizer vaccine. However,…
Results from an analysis of COVID-19 vaccination data from Israel, where most of the population have now been vaccinated, confirm earlier Phase III data and show over 90% protection from asymptomatic and symptomatic disease with the BioNTech/Pfizer vaccine.
Notably, this efficacy held true despite several variants of concern circulating in Israel at the time of vaccination, with the UK B.1.1.7 variant being the most common. While efficacy was good, there was a decrease in efficacy in much older…
-
General22 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
Business22 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors
-
General21 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting
-
General6 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire